CorMedix AMEX CRMD
$5.52 0.27 4.80%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 22 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

316.81M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

273.24M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

2.53
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

57.39M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

46.81 %
Upcoming events CorMedix All events
No upcoming events scheduled

Stock chart CorMedix

Stock analysis CorMedix

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
0.80 -0.09
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
4.52 0.42
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-5.59 -4.43
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.89 0.42
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
562.91 -51.45

Price change CorMedix per year

4.36$ 17.93$
Min Max

Summary analysis CorMedix

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure CorMedix

Revenue and net income CorMedix

All parameters
Stock news CorMedix All news

CorMedix Shares Surge 17% on Better-Than-Expected Loss per Share

CorMedix Shares Surge 17% on Better-Than-Expected Loss per Share

CorMedix Shares Slide Premarket After Public Offering Prices

CorMedix Shares Slide Premarket After Public Offering Prices

CorMedix Shares Drop After Proposed Public Offering

CorMedix Shares Drop After Proposed Public Offering

CorMedix Shares Drop 14% After Type A Meeting With FDA for DefenCath

CorMedix Shares Drop 14% After Type A Meeting With FDA for DefenCath

CorMedix to Resubmit NDA for DefenCath in May

CorMedix to Resubmit NDA for DefenCath in May

Shares of CorMedix Plummet 61% on Delayed FDA Approval of DefenCath

Shares of CorMedix Plummet 61% on Delayed FDA Approval of DefenCath

CorMedix to End European Operations, Neutrolin Distribution >CRMD

CorMedix to End European Operations, Neutrolin Distribution >CRMD

CorMedix: FDA Accepts Resubmission of DefenCath Application

CorMedix: FDA Accepts Resubmission of DefenCath Application

CorMedix Shares Rise Premarket on DefenCath Resubmission to FDA

CorMedix Shares Rise Premarket on DefenCath Resubmission to FDA

CorMedix Says CEO Retires

CorMedix Says CEO Retires

About company CorMedix

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. It primarily focuses on the development of its lead product candidate DefenCath/Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Address:
300 Connell Drive, Berkeley Heights, NJ, United States, 07922
Company name: CorMedix
Issuer ticker: CRMD
ISIN: US21900C3088
Country: USA
Exchange: AMEX
Currency: $
IPO date: 2010-03-25
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.cormedix.com

On which stock exchange are CorMedix (CRMD) stocks traded?

CorMedix (CRMD) stocks are traded on AMEX.

What is the ticker of CorMedix stocks (CRMD)?

The stock ticker of CorMedix’s stocks or in other words, the code is CRMD. The stocks are currently listed on the AMEX exchange.

In which sector and industry does CorMedix (CRMD) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, CorMedix (CRMD) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are CorMedix (CRMD) stocks traded?

CorMedix (CRMD) stocks are traded on the AMEX exchange in dollars.

What is the price of CorMedix (CRMD) stocks today?

The current price of CorMedix stocks on 02.05.2024 is 5.52 dollars. per share.

What is the dynamics of CorMedix (CRMD) stocks from the beginning of the year?

CorMedix (CRMD) quotes have increased by 46.42% from the beginning of the year up to 5.52 dollars. per 1 stocks.

How much did CorMedix (CRMD) stocks increase in мае 2024?

This month CorMedix (CRMD) quotes have increased by 0% to 5.52 dollars. per share.

How much are CorMedix (CRMD) stocks worth?

Today, on October, 02.05.2024 CorMedix’s (CRMD) stocks cost 5.52 dollars..

What is the market capitalization of CorMedix (CRMD)?

Capitalization is the market value of CorMedix (CRMD) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 02.05.2024, the market capitalization of CorMedix (CRMD) is estimated at about 316812352 dollars.